GL1X · GenesisL1 explorer

Research workbench

HCV NS5B polymerase in complex with 1,5 benzodiazepine inhibitor 1B

Analyse HCV NS5B polymerase in complex with 1,5 benzodiazepine inhibitor 1B in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3GNV
Type
protein
Length
1,116 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
O92972
Ligands
XNZ
Pockets
16 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein56349% helix, 15% strandO92972
BRNA-directed RNA polymerase (EC 2.7.7.48)protein55349% helix, 15% strandO92972

Ligands and binding sites

  • XNZ · (11R)-10-acetyl-11-[4-(benzyloxy)-2-chlorophenyl]-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110770.800.8188XNZ
210490.800.8184XNZ
37080.720.7956empty
41380.480.7820empty
5950.440.7920empty

Interfaces

1 interface between chains.

  • A–B · 425 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 3GNV · HCV NS5B polymerase in complex with 1,5 benzodiazepine inhibitor 1b · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.